HKEX has also entered a licensing agreement with E Fund Management to issue an exchange-traded fund in the mainland Chinese market based on the HKEX Tech 100 Index. Photo: Sun Yeung

    Hong Kong launches HKEX Tech 100 Index in pivot towards innovation-driven growth

    Hong Kong Exchanges and Clearing has launched its first equity index tracking Hong Kong-listed technology companies, underscoring the city’s ongoing shift from a market long dominated by property and finance towards innovation-driven growth. Unveiled on Tuesday, the HKEX Tech 100 Index tracks 100 large-cap and mid-cap companies spanning artificial intelligence, biotech and pharmaceuticals, electric vehicles…

    Read More
    HKEX’s first-half profit soars 39% to record HK$8.52 billion on IPO boom, trading volume

    HKEX’s first-half profit soars 39% to record HK$8.52 billion on IPO boom, trading volume

    Hong Kong Exchanges and Clearing (HKEX) set new records for second-quarter and first-half earnings amid a boom in initial public offerings (IPOs) and sizzling stock market turnover, according to a stock exchange filing on Wednesday. Second-quarter net profit for the operator of Asia’s third-largest stock market rose 41 per cent to HK$4.44 billion (US$569 million),…

    Read More
    Hong Kong exchange’s confidential filing option lures tech listing hopefuls, law firm says

    Hong Kong exchange’s confidential filing option lures tech listing hopefuls, law firm says

    Nearly half of the biotech and technology start-ups seeking initial public offerings (IPOs) in Hong Kong are opting for confidential filings under a new listing channel that allows them to protect sensitive data, according to a lawyer with international law firm Cooley. Companies choosing confidential filings often have concerns about sensitive information being released to…

    Read More
    Hong Kong exchange’s confidential filing option lures tech listing hopefuls, law firm says

    Hong Kong exchange’s confidential filing option lures tech listing hopefuls, law firm says

    Nearly half of the biotech and technology start-ups seeking initial public offerings (IPOs) in Hong Kong are opting for confidential filings under a new listing channel that allows them to protect sensitive data, according to a lawyer with international law firm Cooley. Companies choosing confidential filings often have concerns about sensitive information being released to…

    Read More
    Innogen soars in Hong Kong debut as demand for anti-obesity drugs drive biomed bull run

    Innogen soars in Hong Kong debut as demand for anti-obesity drugs drive biomed bull run

    Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals sector, which has enjoyed rising valuations and solid performance. Trading under the stock code 2591, Innogen’s shares first changed hands at HK$72 on Friday, almost four times more than the initial public offering (IPO) price…

    Read More